SVA Sinovac Biotech Ltd.

Fundamentals / CIK 0001084201 / USD

Sinovac Biotech Ltd. reported $386.0M in revenue and a net loss of $59.68M for the fiscal year ended December 31, 2025 (up 6.8% year over year), with a 67.9% gross margin and a -127.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SVA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$19.09B$9.55B$0-$1.70BFY 2016 Revenue: $72.43MFY 2016 Net Income: -$596K2016FY 2017 Revenue: $174.3MFY 2017 Net Income: $25.81M2017FY 2018 Revenue: $229.7MFY 2018 Net Income: $21.78M2018FY 2019 Revenue: $246.1MFY 2019 Net Income: $44.93M2019FY 2020 Revenue: $510.6MFY 2020 Net Income: $110.4M2020FY 2021 Revenue: $19.37BFY 2021 Net Income: $8.12B2021FY 2022 Revenue: $1.47BFY 2022 Net Income: $14.47M2022FY 2023 Revenue: $470.2MFY 2023 Net Income: -$13.49M2023FY 2024 Revenue: $361.4MFY 2024 Net Income: $90.91M2024FY 2025 Revenue: $386.0MFY 2025 Net Income: -$59.68M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $386.0M $361.4M $470.2M $1.47B $19.37B $510.6M $246.1M $229.7M $174.3M $72.43M
Cost of Revenue $124.0M $140.7M $146.9M $658.2M $988.9M $67.18M $32.47M $24.72M $20.24M $22.39M
Gross Profit $262.0M $220.7M $323.3M $815.2M $18.38B $443.4M $213.6M $204.9M $154.1M $50.04M
Research & Development $216.2M $270.7M $350.2M $478.7M $152.7M $48.76M $24.25M $21.91M $20.49M $12.65M
Selling, General & Admin $333.0M $420.9M $598.2M $836.1M $602.1M $176.5M $121.5M $137.0M $87.36M $41.98M
Total Operating Expenses $752.1M $726.2M $1.04B $1.32B $758.1M $227.8M $145.0M $159.6M $108.7M $49.53M
Operating Income -$490.1M -$505.5M -$714.0M -$509.0M $17.62B $215.6M $68.56M $45.32M $45.42M $504K
EBITDA -$391.4M -$394.3M -$555.5M -$355.8M $17.70B $219.4M $73.14M $50.20M $50.05M $5.57M
Interest Income $33.28M $29.07M $87.12M $157.4M $102.6M $1.93M $2.00M $2.02M $1.18M $731K
Interest Expense $9.82M $5.64M $4.94M $1.26M $2.84M $1.45M $650K $1.07M $1.57M $1.73M
Income Before Tax -$262.1M $42.84M -$84.49M -$48.48M $17.57B $216.6M $70.82M $46.58M $45.04M -$394K
Income Tax Expense -$63.27M $2.18M $36.37M $11.48M $3.45B $31.44M $5.61M $10.47M $8.34M $2.66M
Net Income -$59.68M $90.91M -$13.49M $14.47M $8.12B $110.4M $44.93M $21.78M $25.81M -$596K
Basic EPS -$0.83 $1.27 -$0.19 $0.20 $113.54 $2.34 $0.93 $0.75 $0.99 -$0.02
Diluted EPS -$0.83 $1.27 -$0.19 $0.20 $113.44 $2.14 $0.91 $0.75 $0.99 -$0.02
Basic Shares Outstanding 71.9M 71.9M 71.8M 71.7M 71.5M 44.7M 42.9M 29.3M 25.8M 25.8M
Diluted Shares Outstanding 71.9M 71.9M 71.9M 71.8M 71.6M 51.4M 49.6M 29.4M 25.8M 25.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for SVA.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $488.2M $335.3M $1.12B $3.88B $11.61B $1.04B $152.7M $158.2M $114.4M $62.43M
Short-Term Investments $5.48B $9.61B $9.89B $6.65B $1.81B $135.2M $50.27M $18.91M -- --
Cash & Short-Term Investments $5.97B $9.95B $11.02B $10.53B $13.42B $1.18B $203.0M $177.1M $114.4M $62.43M
Accounts Receivable, Net $286.3M $300.9M $424.9M $486.6M $942.7M $253.5M $113.7M $74.46M $66.20M $49.83M
Inventory $94.31M $96.92M $135.6M $175.3M $391.1M $105.8M $27.85M $25.09M $19.62M $14.10M
Total Current Assets $7.06B $10.64B $11.60B $11.30B $14.94B $1.56B $349.6M $284.2M $203.9M $130.7M
Property, Plant & Equipment, Net $706.1M $881.0M $952.0M $989.7M $855.0M $200.4M $74.31M $70.92M $76.43M $66.88M
Goodwill $12.60M $27.51M $0 $0 $0 -- -- -- -- --
Intangible Assets $77.68M $122.6M $8.52M $9.70M $1.48M $1.47M -- -- -- --
Long-Term Investments $512.3M $491.3M $879.8M $1.43B $655.8M -- -- -- -- --
Other Non-Current Assets $18.28M $20.49M $20.91M $19.21M $1.61M -- -- -- $528K $964K
Total Non-Current Assets $1.48B $1.69B $2.01B $2.73B $1.82B $341.0M $102.7M $85.61M $95.33M $80.61M
Total Assets $8.54B $12.34B $13.61B $14.03B $16.76B $1.90B $452.3M $369.8M $299.2M $211.4M
Accounts Payable $16.23M $12.25M $12.95M $19.88M $58.47M $30.54M $5.78M $5.53M $6.78M $1.83M
Short-Term Debt -- -- -- -- -- -- -- $3.32M $18.15M $31.28M
Deferred Revenue (Current) $11.27M $12.21M $27.05M $25.54M $79.72M $363.8M $5.46M $2.91M $4.07M $2.77M
Total Current Liabilities $1.54B $1.45B $1.29B $1.26B $2.52B $679.6M $87.20M $58.20M $92.54M $66.26M
Long-Term Debt $494.9M $375.8M $253.9M $11.81M $15.77M $35.10M $5.93M -- -- --
Deferred Revenue (Non-Current) -- $0 $200K $206K $223K -- $0 $90K $0 $89K
Other Non-Current Liabilities $24K $23K $40K $35K $319K $865K $1.73M $3.00M $3.14M $2.94M
Total Non-Current Liabilities $605.1M $592.0M $676.8M $530.8M $687.0M $101.6M $12.90M $19.65M $29.54M $15.43M
Total Liabilities $2.15B $2.04B $1.97B $1.79B $3.21B $781.2M $100.1M $77.85M $122.1M $81.69M
Total Debt (incl. Leases) $505.6M $391.3M $299.0M $70.31M $138.6M $124.1M $12.23M $7.21M $33.00M $40.73M
Common Stock $72K $72K $72K $72K $72K $99K $99K $71K $57K $57K
Retained Earnings $2.82B $6.84B $6.79B $6.80B $6.81B $144.2M $56.73M $23.82M $9.13M -$11.91M
Accumulated Other Comp. Income -$513.3M -$707.8M -$563.4M -$401.3M $129.5M $19.93M -$4.32M -$2.10M $7.08M $168K
Total Stockholders' Equity $4.44B $8.26B $8.32B $8.49B $9.00B $746.5M $294.0M $253.4M $151.2M $115.8M
Total Equity $6.40B $10.29B $11.64B $12.24B $13.55B $1.13B $352.2M $291.9M $177.1M $129.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Cash & Cash Equivalents $488.2M $335.3M $1.12B $3.88B $11.61B $1.04B $152.7M $158.2M
Short-Term Investments $5.48B $9.61B $9.89B $6.65B $1.81B $135.2M $50.27M $18.91M
Cash & Short-Term Investments $5.97B $9.95B $11.02B $10.53B $13.42B $1.18B $203.0M $177.1M
Accounts Receivable, Net $286.3M $300.9M $424.9M $486.6M $942.7M $253.5M $113.7M $74.46M
Inventory $94.31M $96.92M $135.6M $175.3M $391.1M $105.8M $27.85M $25.09M
Total Current Assets $7.06B $10.64B $11.60B $11.30B $14.94B $1.56B $349.6M $284.2M
Property, Plant & Equipment, Net $706.1M $881.0M $952.0M $989.7M $855.0M $200.4M $74.31M $70.92M
Goodwill $12.60M $27.51M $0 $0 $0 -- -- --
Intangible Assets $77.68M $122.6M $8.52M $9.70M $1.48M $1.47M -- --
Long-Term Investments $512.3M $491.3M $879.8M $1.43B $655.8M -- -- --
Other Non-Current Assets $18.28M $20.49M $20.91M $19.21M $1.61M -- -- --
Total Non-Current Assets $1.48B $1.69B $2.01B $2.73B $1.82B $341.0M $102.7M $85.61M
Total Assets $8.54B $12.34B $13.61B $14.03B $16.76B $1.90B $452.3M $369.8M
Accounts Payable $16.23M $12.25M $12.95M $19.88M $58.47M $30.54M $5.78M $5.53M
Short-Term Debt -- -- -- -- -- -- -- $3.32M
Deferred Revenue (Current) $11.27M $12.21M $27.05M $25.54M $79.72M $363.8M $5.46M $2.91M
Total Current Liabilities $1.54B $1.45B $1.29B $1.26B $2.52B $679.6M $87.20M $58.20M
Long-Term Debt $494.9M $375.8M $253.9M $11.81M $15.77M $35.10M $5.93M --
Deferred Revenue (Non-Current) -- $0 $200K $206K $223K -- $0 $90K
Other Non-Current Liabilities $24K $23K $40K $35K $319K $865K $1.73M $3.00M
Total Non-Current Liabilities $605.1M $592.0M $676.8M $530.8M $687.0M $101.6M $12.90M $19.65M
Total Liabilities $2.15B $2.04B $1.97B $1.79B $3.21B $781.2M $100.1M $77.85M
Total Debt (incl. Leases) $505.6M $391.3M $299.0M $70.31M $138.6M $124.1M $12.23M $7.21M
Common Stock $72K $72K $72K $72K $72K $99K $99K $71K
Retained Earnings $2.82B $6.84B $6.79B $6.80B $6.81B $144.2M $56.73M $23.82M
Accumulated Other Comp. Income -$513.3M -$707.8M -$563.4M -$401.3M $129.5M $19.93M -$4.32M -$2.10M
Total Stockholders' Equity $4.44B $8.26B $8.32B $8.49B $9.00B $746.5M $294.0M $253.4M
Total Equity $6.40B $10.29B $11.64B $12.24B $13.55B $1.13B $352.2M $291.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$198.8M $40.66M -$120.9M -$59.97M $14.12B $185.2M $65.22M $36.11M $36.70M -$720K
Depreciation & Amortization $98.78M $111.3M $158.4M $153.1M $85.25M $3.80M $4.58M $4.89M $4.64M $5.06M
Stock-Based Compensation $0 $0 $0 $0 $7.74M $10.20M $3.00M $4.30M $979K $2.41M
Change in Receivables $24.27M $87.73M $41.41M $389.9M -$676.6M -$128.0M -$40.19M -$13.08M -$13.48M -$15.12M
Change in Inventory -$23.02M -$665K -$14.86M $26.89M -$325.1M -$77.74M -$3.65M -$9.41M -$5.53M -$3.02M
Operating Cash Flow -$512.2M -$56.89M $138.6M -$798.1M $15.32B $479.3M $39.07M $7.94M $59.76M -$13.90M
Capital Expenditure -$48.92M -$95.96M -$156.2M -$313.9M -$594.2M -$127.5M -$10.63M -$5.61M -$11.91M -$12.65M
Free Cash Flow -$561.1M -$152.9M -$17.52M -$1.11B $14.73B $351.8M $28.45M $2.33M $47.84M -$26.56M
Acquisitions, Net -$14.15M -$100.2M $0 $0 $0 -- -- -- -- --
Sales & Maturities of Investments $10.67B $5.59B $2.51B $19.71B $4.74B $124.6M -- -- -- --
Investing Cash Flow $4.39B $456.4M -$2.70B -$6.09B -$2.98B -$204.8M -$42.45M -$25.26M -$11.90M -$11.78M
Common Stock Issued $0 $0 $676K $0 $1.03M $2.00M $0 $85.30M $1.26M $315K
Dividends Paid -$3.53B -$947.0M -$328.1M -$247.4M -$1.88B $0 $0 -- -- --
Financing Cash Flow -$3.43B -$824.0M -$88.55M -$299.5M -$1.91B $592.6M $1.74M $64.18M -$1.34M $27.78M
Net Change in Cash $554.2M -$526.9M -$2.76B -$7.73B $10.57B $894.3M -$2.29M $42.21M $50.52M -$162K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for SVA.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 67.9% 61.1% 68.8% 55.3% 94.9% 86.8% 86.8% 89.2% 88.4% 69.1%
Operating Margin -127.0% -139.9% -151.9% -34.5% 91.0% 42.2% 27.9% 19.7% 26.0% 0.7%
Net Profit Margin -15.5% 25.2% -2.9% 1.0% 41.9% 21.6% 18.3% 9.5% 14.8% -0.8%
Return on Equity (ROE) -1.3% 1.1% -0.2% 0.2% 90.3% 14.8% 15.3% 8.6% 17.1% -0.5%
Return on Assets (ROA) -0.7% 0.7% -0.1% 0.1% 48.5% 5.8% 9.9% 5.9% 8.6% -0.3%
Current Ratio 4.59x 7.33x 8.97x 9.00x 5.93x 2.30x 4.01x 4.88x 2.20x 1.97x
Quick Ratio 4.53x 7.26x 8.87x 8.86x 5.78x 2.14x 3.69x 4.45x 1.99x 1.76x
Debt to Equity 0.11x 0.05x 0.04x 0.01x 0.02x 0.17x 0.04x 0.03x 0.22x 0.35x
Revenue Growth (YoY) +6.8% -23.1% -68.1% -92.4% +3692.5% +107.5% +7.1% +31.7% +140.7% +7.4%
Gross Profit Growth (YoY) +18.7% -31.7% -60.3% -95.6% +4044.0% +107.6% +4.2% +33.0% +208.0% +2.1%
Operating Income Growth (YoY) -- -- -- -102.9% +8070.1% +214.5% +51.3% -0.2% +8911.3% -86.4%
Net Income Growth (YoY) -165.7% -- -193.3% -99.8% +7259.1% +145.7% +106.3% -15.6% -- --
EPS Growth (YoY) -165.4% -- -195.0% -99.8% +4745.3% +152.4% +23.5% -24.4% -- --
Operating Cash Flow Growth (YoY) -- -141.0% -- -105.2% +3096.7% +1126.7% +391.9% -86.7% -- -430.1%
Free Cash Flow Growth (YoY) -- -- -- -107.6% +4086.1% +1136.8% +1120.9% -95.1% -- --
5Y Revenue / Share Growth -52.9% -12.3% -16.5% +204.0% +9528.2% +331.3% +129.5% +173.4% +241.2% +22.2%
10Y Revenue / Share Growth +103.0% +101.3% +128.1% +937.1% +11664.7% +720.3% +31.2% -- -- --
5Y Net Income / Share Growth -133.7% +20.8% -125.2% -79.8% -- -- -- +150.1% -- --
10Y Net Income / Share Growth -- -- -163.1% -- -- -- +1.0% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for SVA.
Source: SEC EDGAR CompanyFacts (CIK 0001084201) · from December 31, 2009 Data through December 31, 2025 · synced Nov 20, 2026, 05:37 UTC · Open in terminal